vimarsana.com
Home
Live Updates
Silver Creek Presents ARPEGGIO, a Phase 2 Clinical Trial Eva
Silver Creek Presents ARPEGGIO, a Phase 2 Clinical Trial Eva
Silver Creek Presents ARPEGGIO, a Phase 2 Clinical Trial Evaluating Scp776 -- a First-in-Class Cell Rescue Drug -- for the Treatment of Acute Ischemic Stroke
/PRNewswire/ -- Silver Creek, a biotechnology company headquartered in San Francisco, presented the ARPEGGIO study at the International Stroke Conference in...
Related Keywords
United States ,
Silver Creek ,
California ,
Dallas ,
Texas ,
San Francisco ,
American ,
Lakhmir Chawla ,
International Stroke Conference ,
American Heart Association International Stroke Conference ,
Silver Creek Pharmaceuticals ,
American Heart Association ,
Ongoing Clinical Trial ,
Smart Growth Factor ,
Private Securities Litigation Reform Act ,